Pressure BioSciences Inc (OTCMKTS:PBIO) has been added to the prestigious Richmond Club Index, which has outperformed the S&P 500 Index by an average of 11% each year since its inception ten years ago, the company announced on Tuesday.
The Richmond Club boasts roughly 550 members, comprised of a mix of investment advisors, fund managers, analysts, and members of the media.
Pressure BioSciences is a leader in the development and sale of broadly enabling pressure cycling technology ("PCT")-based sample preparation solutions to the worldwide life sciences industry.
Inclusion in the Richmond Club Index is difficult to achieve. To be invited, the Richmond Club initially screens thousands of publicly-traded companies, chooses a few to interview, then selects the best company among the finalists that it believes is the most undervalued relative to its peers, and also offers excellent growth potential.
"This new investor recognition, building upon PBI's recent growth momentum together with important financial, strategic marketing, and new product achievements, lead us to believe that 2016 will be our most successful year to date," said Richard T. Schumacher, President and CEO of PBI.